Spontaneous and experimental models of lymph node metastasis.

Area of Science:

• Oncology
• Immunology
• Preclinical Models

Background:

• Lymph node (LN) metastasis is common in solid tumors and linked to poor prognosis.
• LN metastases can cause systemic immune tolerance and facilitate distant spread.
• Existing preclinical models for studying LN metastasis and its systemic effects are limited.

Purpose of the Study:

• To establish and validate novel preclinical models for investigating melanoma lymph node metastasis.
• To enable the assessment of tumor and immune cell phenotypes within LNs.
• To study the functional role of LN involvement in distant metastasis and immune reprogramming.

Main Methods:

• Developed transplantable syngeneic melanoma cell lines with enhanced LN metastatic potential.
• Established a spontaneous LN metastasis model via primary tumor implantation (21-28 days).
• Established an experimental LN metastasis model using direct intra-LN tumor cell injection.

Main Results:

• The models allow for assessment of LN colonization and its impact on distant metastases.
• These models facilitate the study of cancer-immune interactions in the LN microenvironment.
• The models are suitable for evaluating novel anti-metastatic therapeutics.

Conclusions:

• The developed models provide accessible tools for studying LN metastasis biology in melanoma.
• These models can profile immune reprogramming and measure the impact of LN metastasis on distant spread.
• The models support the evaluation of new therapeutic strategies against metastasis.